Valeant Stock Rocked Anew By Earnings, Default Warnings
Valeant Pharmaceuticals International Inc.'s shares plunged again Tuesday as the Canadian drugmaker sharply cut its earnings guidance for the coming year and warned that a delay in filing its annual report...To view the full article, register now.
Already a subscriber? Click here to view full article